Legal News

Orphan drugs and Teva v EMA

Published on: 23 March 2016

Table of contents

  • Original news
  • What was the background to this case?
  • What did the court have to decide?
  • What was the outcome?
  • Are there any wider lessons for lawyers to take from this case?

Article summary

IP & IT analysis: George Peretz QC of Monckton Chambers explores Teva v EMA and explains why the Court of Justice of the European Union (CJEU) opted for a decision that appears to serve the objective emphasised in the recitals to Regulation (EC) 141/2000.

Popular documents